Madrigal Pharmaceuticals Semi Deviation
| MDGL Stock | | | USD 513.72 -3.67 -0.71% |
Semi-deviation provides a good measure of downside risk for a equity or a portfolio. It is similar to standard deviation, but it only looks at periods where the returns are less than the target or average level. Below is Madrigal Pharmaceuticals's current Semi Deviation with peer comparisons and related risk metrics.
Current Semi Deviation Value
Madrigal Pharmaceuticals's Semi Deviation of 2.44 reflects moderate price variability. This places Madrigal Pharmaceuticals within the typical volatility range for Biotechnology.
Semi Deviation | = | SQRT(SV) |
| = | 2.44 | |
Semi Deviation Peers Comparison
The peer group averages 2.37 for Semi Deviation, with Madrigal Pharmaceuticals at 2.44 falling above that level. Readings span 1.29 (Jazz Pharmaceuticals PLC) to 3.24 (Moderna). Madrigal Pharmaceuticals has exhibited greater price dispersion than the peer average over the measured period.
Semi Deviation Relative To Other Indicators
The chart below plots Semi Deviation against Maximum Drawdown for Madrigal Pharmaceuticals and its peers. Each point represents one equity — position along the horizontal axis shows Semi Deviation while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
The Maximum Drawdown-to-Semi Deviation ratio for Madrigal Pharmaceuticals sits near
6.74 , with Semi Deviation at
2.44 and Maximum Drawdown at
16.42 . This indicates Maximum Drawdown substantially exceeds Semi Deviation for Madrigal Pharmaceuticals.
Methodology, Assumptions & Data Sources
Madrigal Pharmaceuticals has a current Semi Deviation reading of 2.44. Semi Deviation for Madrigal Pharmaceuticals is derived by applying a defined formula to historical price observations, producing a time-series of comparable readings. The underlying data comes from exchange-reported daily closes with corporate action adjustments applied where relevant. Madrigal Pharmaceuticals operates in the health care sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. The output reflects the selected calculation window — changing the horizon will produce different readings. This stock metric is provided for analytical reference.
Other Technical Indicators